Given how often Epstein's name comes up here, thought this would be of interest. If folks don't have a Medpage account I can post the text:
Jonathan Epstein on Gleason 6 - Prostate Cancer N...
Jonathan Epstein on Gleason 6
Here's the other side of the argument from a decade ago:
sciencedirect.com/science/a...
Another roadblock to renaming are IRBs. They will not allow hospitals to rename or even test the hypothesis via RCT until there is evidence of non-inferiority. And without an RCT, it is impossible to get that evidence.
There was a hypothetical survey (asking well men to imagine how they would react), but hypotheticals don't necessarily predict what they would really do:
acsjournals.onlinelibrary.w...
Sure, and given the debacle after the 2021 USPSTF statement giving a "D" to PSA screening, I can certainly understand why those who might otherwise undertake a study are gun-shy. I know there are similar issues with DCIS in breast cancer and in papillary thyroid cancer, though I can't remember nearly the same amount of screaming and hair pulling (but maybe that's because I'm not so close to those other dubious "cancers").